We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Postmarket Reporting Forms Detailed in Draft Guidance
New Postmarket Reporting Forms Detailed in Draft Guidance
The FDA has developed two new documents that it wants drug sponsors to use for annual postmarket reporting and is requesting comments on them in a new draft guidance.